Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study

Abstract The effect of blood pressure (BP) on the incident cardiovascular events, progression to end-stage renal disease (ESRD) and mortality were evaluated among chronic kidney disease (CKD) patients with and without antihypertensive treatment. This nationwide study used the Korean National Health...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: You-Bin Lee, Ji Sung Lee, So-hyeon Hong, Jung A. Kim, Eun Roh, Hye Jin Yoo, Sei Hyun Baik, Kyung Mook Choi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f5711952a1c54440aa84da1849a19023
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f5711952a1c54440aa84da1849a19023
record_format dspace
spelling oai:doaj.org-article:f5711952a1c54440aa84da1849a190232021-12-02T15:22:57ZOptimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study10.1038/s41598-021-81328-y2045-2322https://doaj.org/article/f5711952a1c54440aa84da1849a190232021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81328-yhttps://doaj.org/toc/2045-2322Abstract The effect of blood pressure (BP) on the incident cardiovascular events, progression to end-stage renal disease (ESRD) and mortality were evaluated among chronic kidney disease (CKD) patients with and without antihypertensive treatment. This nationwide study used the Korean National Health Insurance Service-Health Screening Cohort data. The hazards of outcomes were analysed according to the systolic BP (SBP) or diastolic BP (DBP) among adults (aged ≥ 40 years) with CKD and without previous cardiovascular disease or ESRD (n = 22,278). The SBP and DBP were ≥ 130 mmHg and ≥ 80 mmHg in 10,809 (48.52%) and 11,583 (51.99%) participants, respectively. During a median 6.2 years, 1271 cardiovascular events, 201 ESRD incidents, and 1061 deaths were noted. Individuals with SBP ≥ 130 mmHg and DBP ≥ 80 mmHg had higher hazards of hypertension-related adverse outcomes compared to the references (SBP 120–129 mmHg and DBP 70–79 mmHg). SBP < 100 mmHg was associated with hazards of all-cause death, and composite of ESRD and all-cause death during follow-up only among the antihypertensive medication users suggesting that the BP should be < 130/80 mmHg and the SBP should not be < 100 mmHg with antihypertensive agents to prevent the adverse outcome risk of insufficient and excessive antihypertensive treatment in CKD patients.You-Bin LeeJi Sung LeeSo-hyeon HongJung A. KimEun RohHye Jin YooSei Hyun BaikKyung Mook ChoiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
You-Bin Lee
Ji Sung Lee
So-hyeon Hong
Jung A. Kim
Eun Roh
Hye Jin Yoo
Sei Hyun Baik
Kyung Mook Choi
Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study
description Abstract The effect of blood pressure (BP) on the incident cardiovascular events, progression to end-stage renal disease (ESRD) and mortality were evaluated among chronic kidney disease (CKD) patients with and without antihypertensive treatment. This nationwide study used the Korean National Health Insurance Service-Health Screening Cohort data. The hazards of outcomes were analysed according to the systolic BP (SBP) or diastolic BP (DBP) among adults (aged ≥ 40 years) with CKD and without previous cardiovascular disease or ESRD (n = 22,278). The SBP and DBP were ≥ 130 mmHg and ≥ 80 mmHg in 10,809 (48.52%) and 11,583 (51.99%) participants, respectively. During a median 6.2 years, 1271 cardiovascular events, 201 ESRD incidents, and 1061 deaths were noted. Individuals with SBP ≥ 130 mmHg and DBP ≥ 80 mmHg had higher hazards of hypertension-related adverse outcomes compared to the references (SBP 120–129 mmHg and DBP 70–79 mmHg). SBP < 100 mmHg was associated with hazards of all-cause death, and composite of ESRD and all-cause death during follow-up only among the antihypertensive medication users suggesting that the BP should be < 130/80 mmHg and the SBP should not be < 100 mmHg with antihypertensive agents to prevent the adverse outcome risk of insufficient and excessive antihypertensive treatment in CKD patients.
format article
author You-Bin Lee
Ji Sung Lee
So-hyeon Hong
Jung A. Kim
Eun Roh
Hye Jin Yoo
Sei Hyun Baik
Kyung Mook Choi
author_facet You-Bin Lee
Ji Sung Lee
So-hyeon Hong
Jung A. Kim
Eun Roh
Hye Jin Yoo
Sei Hyun Baik
Kyung Mook Choi
author_sort You-Bin Lee
title Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study
title_short Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study
title_full Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study
title_fullStr Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study
title_full_unstemmed Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study
title_sort optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/f5711952a1c54440aa84da1849a19023
work_keys_str_mv AT youbinlee optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy
AT jisunglee optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy
AT sohyeonhong optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy
AT jungakim optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy
AT eunroh optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy
AT hyejinyoo optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy
AT seihyunbaik optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy
AT kyungmookchoi optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy
_version_ 1718387406576549888